Technique of Laparoscopic Hysterectomy and Pelvic Lymphadenectomy for Endometrial Cancer

Pookunju, Ansar Pullampara; Ayyappan, S.

doi:10.1007/s13193-017-0690-x

Cited by 5 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of the patients in the present study were obese and we agreed with Mueller et al [20] and Pookunju et al [21] in that when compared to the laparoscopic hysterectomy to abdominal hysterectomy, the laparoscopic access route is better and has less risk of complications for people with a high body mass index [BMI]. Ansar et al [22] al believed that performing pelvic lymphadenectomy first will help them to dissect the uterine artery and ureter easily.…”

Section: Discussionsupporting

confidence: 84%

Laparoscopic Hysterectomy and Pelvic Lymphadenectomy for Early Endometrial Carcinoma

Asar

Abou-Ashour

Fayed

2023

International Journal of Medical Arts

View full text Add to dashboard Cite

Article informationBackground: Endometrial carcinoma is a common female malignancy. Accurate staging of endometrial carcinoma is crucial, as the treatment plane depends on the tumour stage. Surgical excision is the gold-slandered treatment for such cases. Aim of the work:This study aims to assess the surgical outcomes of laparoscopic hysterectomy and pelvic lymphadenectomy in early endometrial carcinoma. Patients and Methods: A total of 30 patients with early endometrial carcinoma were collected prospectively. The study was done at Menoufia university hospital and Bab-Elsheria Hospital in Egypt. All patients underwent laparoscopic Hysterectomy, Bilateral salpingooophorectomy, and pelvic lymphadenectomy [HBSO&PLA]. Results: The mean age of patients was 53±3 years. The mean operative time was 142± 14 minutes. Hospital stay was 2 ± 1 day. The perioperative complications included intraoperative bleeding in 2 patients [6.66 %] and port site infection in one patient [3.3 %], with no DVT or mortality. Conclusion: Laparoscopic surgery for endometrial carcinoma is safe, feasible, and of great benefit in reducing the time for a hospital stay, less postoperative pain, early return to work, good in retrieving pelvic lymph nodes, provide proper surgical staging, and has a low rate of complications

show abstract

Section: Discussionsupporting

confidence: 84%

Laparoscopic Hysterectomy and Pelvic Lymphadenectomy for Early Endometrial Carcinoma

Asar

Abou-Ashour

Fayed

2023

International Journal of Medical Arts

View full text Add to dashboard Cite

show abstract

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

et al. 2021

View full text Add to dashboard Cite

Initiated through ESGO the decision to develop multidisciplinary guidelines has been made jointly by the ESGO, ESTRO, and ESP. The ESGO has provided administrative support. The ESGO, ESTRO and ESP are nonprofit knowledgeable societies.The development group (including all authors) is collectively responsible for the decision to submit for publication. Nicole Concin (chair), Carien L. Creutzberg (cochair), Xavier Matias-Guiu (co-chair) and François Planchamp (methodologist) have written the first draft of the manuscript. All other contributors have actively given personal input, reviewed the manuscript, and have given final approval before submission.

show abstract

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Concin

Matías‐Guiu

Vergote

et al. 2021

Radiotherapy and Oncology

170

203

View full text Add to dashboard Cite

A European consensus conference on endometrial carcinoma was held in 2014 to produce multidisciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide. ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of endometrial carcinoma (27 experts across Europe). To ensure that the guidelines are evidence-based, the literature published since 2014, identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the

show abstract

Technique of Laparoscopic Hysterectomy and Pelvic Lymphadenectomy for Endometrial Cancer

Cited by 5 publications

References 2 publications

Laparoscopic Hysterectomy and Pelvic Lymphadenectomy for Early Endometrial Carcinoma

Laparoscopic Hysterectomy and Pelvic Lymphadenectomy for Early Endometrial Carcinoma

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Contact Info

Product

Resources

About